Update: Story expanded with statement from Oura
After a stint away from the American market, due to a patent infringement case, Ultrahuman has cleared US Customs and Border Protection and is officially back for sale in the country.
It’s welcome news for US customers, and Ultrahuman is one of the few smart rings that gives you access to all tracking data without requiring a subscription. Even better news is that if you are one of the first buyers, you can get it at a steep discount.
What makes Ring PRO worth your attention?
Let’s start with the battery life. Ring PRO offers up to 15 days on a single charge. Pair it with the new PRO Charging Case, and that jumps to 45 days. That’s not a typo. You could go a month and a half without needing a charger.
The ring is built from a titanium unibody and runs on a dual-core processor with on-chip machine learning for more accurate health insights. It can store up to 250 days of health data directly on the device, so you aren’t constantly tethered to your phone.
Other notable features include up to 100 meters (328 feet) of water resistance, find my case, and wireless charging for the case, among others.
If you want more, optional PowerPlugs add medical-grade features like AFib detection, a world first on a smart ring, ovulation tracking with 90% plus accuracy, snoring analysis, and even GLP-1 medication monitoring.
Do you need to pay a subscription?
No, and that’s the best part. Unlike its competitors, Ultrahuman does not lock core health tracking behind a monthly paywall. Sleep, recovery, stress, and movement data are all free.
Any special introductory price?
To make the launch more appealing to consumers, Ultrahuman is offering an early bird pricing starting at $349 for the first 1,000 orders, which includes both Ring PRO and the PRO Charging Case.
That’s $130 off the standard bundle price of $479. The price increases as tiers fill, so act fast. You can pre-order tomorrow morning, with shipping beginning on May 15.
Oura has reached out to us and provided the following statement:
‘Since 2013, Oura has led smart ring innovation and protected it through a broad, validated IP portfolio, with ITC exclusion orders, court decisions upholding key patents, and long-term licensing agreements. Our focus remains on serving members with best-in-class accuracy and insights, and on ensuring this category advances on a foundation of originality, clinical rigor, and respect for intellectual property.
The recent CBP decision is not a final or comprehensive ruling on Ultrahuman’s new design. It is a narrow, initial customs determination about one Oura patent and one Ultrahuman ring design; it does not resolve our broader patent disputes in the Eastern District of Texas where we’ve asserted several additional U.S. patents against Ultrahuman and cited concerns regarding their credibility and conduct in this dispute. We are reviewing the initial ruling closely and evaluating next steps, including potential appeals and additional enforcement options where appropriate.’
